Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,743 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06512688Recruiting
Fat-Soluble Vitamin Levels in Healthy Chinese Adults
This study is measuring the normal levels of fat-soluble vitamins (like vitamins A, D, E, and K) in the blood of healthy Chinese adults. It helps doctors understand what healthy vitamin levels look like.
Hangzhou, ZhejiangAges 18 years+ - NCT06516874Recruiting
Trauma-focused therapy for PTSD in adults
This study tests a therapy called trauma-focused cognitive-behavioral therapy (TF-CBT) for adults with PTSD or complex PTSD. It aims to see if this approach can help people who have been through traumatic events feel better.
Curicó, Maule RegionAges 18–64 - NCT06519253Recruiting
Virtual reality music for older hospital patients
This study tests whether listening to music through a virtual reality headset can improve the well-being of older adults staying in the hospital. If you are 60 or older and medically stable, you may be able to join and try this relaxing experience.
Montreal, QuebecAges 60 years+ - NCT06519682Recruiting
Immunotherapy for young people with a specific brain tumor
This trial is testing a new immunotherapy (nivolumab) for children, teens, and young adults with a specific type of aggressive brain tumor (glioblastoma that has a DNA repair problem). It aims to see if giving this treatment early, right after surgery, can help the immune system fight the tumor.
Toronto, OntarioAges 1–25 - NCT06520878RecruitingPhase 2
Nano-PSO for memory loss in older adults
This trial tests a supplement called NANO-PSO to see if it can help thinking and memory in older adults with mild to moderate memory problems. It may be an option for people with early Alzheimer's disease.
Miguel Hidalgo, Mexico CityAges 60 years+ - NCT06521671Recruiting
Fracture healing after hip surgery in younger adults
This trial tests whether a new surgical method helps hip fractures heal better in adults aged 18 to 64. It uses special X-rays to track how the bone moves over time.
AarhusAges 18–65 - NCT06522750Recruiting
Periodic fasting for long COVID in adults
This study tests whether periodic fasting can help adults with long COVID. You may qualify if you are 18-64, have had COVID symptoms for at least 12 weeks, have a normal weight and low iron stores.
EttelbruckAges 18–64 - NCT06524635RecruitingPhase 2
Study of lutikizumab for hidradenitis suppurativa or eczema
This study tests an investigational medicine called lutikizumab, given as shots under the skin, for people with moderate-to-severe hidradenitis suppurativa (HS) or atopic dermatitis (eczema). It looks at how the medicine affects skin changes and may help if other treatments haven’t worked.
Sacramento, CaliforniaAges 18–75 - NCT06525636RecruitingPhase 1/Phase 2
Study of a new drug (KK8123) for adults with XLH
This study tests a new investigational drug called KK8123 for adults with X-linked hypophosphatemia (XLH). It aims to see if KK8123 can safely raise low blood phosphorus levels. The trial includes two parts and may offer a new treatment option if you have not used burosumab recently.
San Francisco, CaliforniaAges 18–65 - NCT06526208RecruitingPhase 2
Marijuana-based compound for anxiety in autistic adults
This study tests a marijuana-based compound (similar to CBD but not psychoactive) to see if it helps reduce anxiety in autistic adults. You would take a daily capsule and be monitored for 12 weeks.
Phoenix, ArizonaAges 18–45 - NCT06530992Recruiting
Tucking and semen quality in adult trans women
This study looks at whether tucking affects semen quality in adult transgender women who are about to start or are on hormone therapy. The results could help patients understand how tucking might impact their fertility options.
InnsbruckAges 18–50 - NCT06532552RecruitingPhase 2
Comparing four drug combinations for older or unfit AML patients
This trial compares four different combinations of targeted therapy and chemotherapy for people with newly diagnosed AML who cannot have standard intensive chemo. The goal is to see which combination works best safely.
Suzhou, JiangsuAges 18 years+ - NCT06533761RecruitingPhase 1
Eganelisib alone or with chemo for relapsed AML
This trial tests an experimental drug called eganelisib, either alone or with the chemotherapy drug cytarabine, for people with relapsed or refractory acute myeloid leukemia (AML) or certain high-risk myelodysplastic syndromes (MDS). It aims to see if the drug is safe and can help control the cancer.
Duarte, CaliforniaAges 18 years+ - NCT06533943Recruiting
Beach park physical activity study in Rimini
This study looks at whether physical activity done in a blue-green space (like a park by the sea) is good for your health. It is open to adults living in Rimini who can follow simple exercise instructions.
Rimini, RiminiAges 18 years+ - NCT06538480RecruitingPhase 4
Zopa retreatment study for recurrent respiratory papillomatosis
This trial tests if people with recurrent respiratory papillomatosis (growths in the airway caused by HPV) can safely get more doses of the study drug Zopa and checks if the virus spreads after treatment. It may help people who have already tried Zopa or are considering it for the first time.
Atlanta, GeorgiaAges 18 years+ - NCT06538064Recruiting
Study of HyQvia for Adults with CIDP in Routine Care
This study looks at how well HyQvia works for adults with CIDP in everyday medical practice. It includes people who are already using HyQvia or are switching to it.
Rancho Mirage, CaliforniaAges 18 years+ - NCT06538974Recruiting
Long-term use of an exoskeleton for leg weakness
This trial tests a walking device called an exoskeleton to help people with leg weakness or movement problems. It's designed to see if using the exoskeleton regularly over time can help improve walking or mobility.
ParisAges 18 years+ - NCT06544265RecruitingPhase 1
SynKIR-310 for advanced B-cell lymphoma
This trial tests a new treatment called SynKIR-310 for people with B-cell non-Hodgkin lymphoma whose cancer has come back or not responded to at least 2 prior treatments. It may be an option if you've already had CAR T-cell therapy or cannot have it.
Denver, ColoradoAges 18 years+ - NCT06544499RecruitingPhase 3
Efgartigimod for adults with chronic ITP
This study tests an investigational drug called efgartigimod, given through a vein, for adults with chronic immune thrombocytopenia (ITP) who have not responded well to other treatments. The goal is to see if it safely raises platelet counts and reduces bleeding risk.
Phoenix, ArizonaAges 18 years+ - NCT06545123Recruiting
How different exercises affect gut health in older adults with muscle loss
This study looks at how different types of exercise can change the bacteria in your gut for older adults who have muscle loss (sarcopenia). You will be assigned to one of two exercise programs to see which one helps your muscles and gut health the most.
PortoAges 60 years+ - NCT06545435Recruiting
Study on body composition using BIA in adults with obesity
This trial uses a simple test called bioelectrical impedance analysis (BIA) to estimate muscle and fat in adults with obesity, comparing it to a more precise scan (DXA). It aims to see if BIA can reliably measure body composition.
Baton Rouge, LouisianaAges 18 years+ - NCT06548542RecruitingPhase 2
Targeted therapy study for moderate to severe Crohn's disease
This study tests a new targeted therapy for adults with moderate to severe Crohn's disease who haven't responded well to other treatments. It aims to reduce inflammation and improve symptoms.
Dothan, AlabamaAges 18–75 - NCT06549179Recruiting
Testing a tool to diagnose autism in adults
This study tests a new French questionnaire (AMSE) to see how well it can identify autism in adults who are seeking a first diagnosis. It may help you get a clearer answer about whether you have autism.
ParisAges 18 years+ - NCT06549790RecruitingPhase 1
Study of NMS-03597812 for relapsed or refractory AML
This study tests a new experimental drug (NMS-03597812) for adults with AML that has not responded to or has returned after other treatments. The goal is to see if it is safe and if it can help control the leukemia.
Duarte, CaliforniaAges 18 years+
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,743 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.